ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.38
0.74%
US Tech 100
20,836.00
1.31%
S&P 500
5,930.85
1.09%
US Dollar vs CAD
1.43181
-0.03%
Bitcoin
98,218.21
0.47%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Xeris Biopharma Holdings Inc (XERS) Share Price

Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc (XERS)

NASDAQ
3.49
0.08
(2.35%)
Closed December 21 3:00PM
Delayed by 15 minutes
3.50
0.01
(0.29%)
After Hours: 5:38PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
3.50
Bid
3.18
Ask
3.50
Volume
1,524,094
3.35 Day's Range 3.569
1.69 52 Week Range 3.87
Market Cap
521.785M
Previous Close
3.41
Open
3.35
Last Trade
857
@
3.5
(formt)
Last Trade Time
Financial Volume
US$ 5,250,529
VWAP
3.445
Average Volume (3m)
1,575,624
Shares Outstanding
149,081,461
Dividend Yield
-
PE Ratio
-8.33
Earnings Per Share (EPS)
-0.42
Revenue
163.91M
Net Profit
-62.26M

About Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.xerispharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was US$3.41. Over the last year, Xeris Biopharma shares have traded in a share price range of US$ 1.69 to US$ 3.87.

Xeris Biopharma currently has 149,081,461 shares outstanding. The market capitalization of Xeris Biopharma is US$508.37 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -8.33.

Ask ADVFN Intelligence (AI)

XERS Latest News

More News

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

November 26 2024
Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 08 2024
Edgar (US Regulatory)

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Achieved record total revenue of $54.3M including record product revenue of $52.9M Product revenue increased 27% versus prior year and 14% over the prior quarter Ended Q3 with $69.4M in cash...

November 08 2024
Business Wire

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and...

October 31 2024
Business Wire

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a...

October 04 2024
Business Wire

Xeris to Participate in Upcoming Investor Conferences

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

August 22 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

August 09 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

August 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

August 08 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.113.244837758113.393.513.1717173933.32466495CS
40.4514.75409836073.053.873.0217266543.43882192CS
120.6422.37762237762.863.872.6915756243.2394897CS
261.466.66666666672.13.872.0315332212.87203276CS
521.4469.90291262142.063.871.6917124882.62193779CS
1561.1448.30508474582.363.870.970115155472.29394306CS
260-4.18-54.42708333337.688.17910.970118279143.07728594CS

XERS - Frequently Asked Questions (FAQ)

What is the current Xeris Biopharma share price?
The current share price of Xeris Biopharma is US$ 3.50
How many Xeris Biopharma shares are in issue?
Xeris Biopharma has 149,081,461 shares in issue
What is the market cap of Xeris Biopharma?
The market capitalisation of Xeris Biopharma is USD 508.37M
What is the 1 year trading range for Xeris Biopharma share price?
Xeris Biopharma has traded in the range of US$ 1.69 to US$ 3.87 during the past year
What is the PE ratio of Xeris Biopharma?
The price to earnings ratio of Xeris Biopharma is -8.33
What is the cash to sales ratio of Xeris Biopharma?
The cash to sales ratio of Xeris Biopharma is 3.17
What is the reporting currency for Xeris Biopharma?
Xeris Biopharma reports financial results in USD
What is the latest annual turnover for Xeris Biopharma?
The latest annual turnover of Xeris Biopharma is USD 163.91M
What is the latest annual profit for Xeris Biopharma?
The latest annual profit of Xeris Biopharma is USD -62.26M
What is the registered address of Xeris Biopharma?
The registered address for Xeris Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Xeris Biopharma website address?
The website address for Xeris Biopharma is www.xerispharma.com
Which industry sector does Xeris Biopharma operate in?
Xeris Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

XERS Discussion

View Posts
81vette 81vette 4 days ago
8 month trend is tremendously strong in this market!!
👍️0
Firestorm22 Firestorm22 3 weeks ago
Seems a lot like all the hyped pump and dump stocks. I see the same hype from people posting but no results…..hmmmmmm
👍️0
Rkrocks Rkrocks 2 months ago
Monk things starting to take shape
👍️0
Pascal2 Pascal2 5 months ago
We need to rebound to 3 first. Back to level. Normal And to 4. Is possible ..
👍️0
Monksdream Monksdream 9 months ago
XERS under $3
👍️0
StocksNcash StocksNcash 9 months ago
Still here👍
👍️0
Frankestin Frankestin 10 months ago
We are ready?🙏
👍️0
Nadendla Nadendla 10 months ago
ya..:)
👍️0
StocksNcash StocksNcash 10 months ago
Your welcome
👍️0
buccaneer1961 buccaneer1961 10 months ago
Thankyou!
👍️0
StocksNcash StocksNcash 10 months ago
Not really sure, but there has been positive news on this company. My app tip ranks has a forecast $51!! I’m holding lol good luck
👍️0
TrendTrade2016 TrendTrade2016 10 months ago
XERS...3.29 BREAK OUT COMING UP
👍️0
buccaneer1961 buccaneer1961 10 months ago
Green lately..whats the catalysts?
👍️0
StocksNcash StocksNcash 10 months ago
Buy hold and don’t look back$$$$$
👍️0
Monksdream Monksdream 10 months ago
XERS new 52 week high
👍️0
Rkrocks Rkrocks 2 years ago
Let’s hope to break 3.00 soon
👍️0
price_and_volume price_and_volume 3 years ago
Izzy Englander likes $XERS...

https://finance.yahoo.com/news/billionaire-israel-englander-pulls-trigger-133848525.html
👍️0
mess124 mess124 3 years ago
Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after

Strongbridge vanished and XERS showed up.


Thank you
👍️0
Elgordo84 Elgordo84 3 years ago
Yes indeed
👍️0
alchemytrader alchemytrader 3 years ago
Nice catch in the low 2.00s.
👍️0
Elgordo84 Elgordo84 3 years ago
Goodluck to all the Longs!
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Ramping up for sure.
👍️0
Elgordo84 Elgordo84 3 years ago
I like what I see here!

Looks like a Trend reversal

Great with patience!

Let’s go $XERS

#EG84
👍️0
ahimsa27 ahimsa27 3 years ago
PDUFA New Years ?
👍️0
$Money Bags$ $Money Bags$ 3 years ago
They stalled the run when they first announced the merger, then silently listed their failed FDA trial in that q. They have more stuff in the pipeline and once the merger is done, maybe they can ramp revenue.
👍️0
ezyE ezyE 3 years ago
Can we make it rain here?
👍️0
kzivann kzivann 3 years ago
Premarket action .. nice news.


XERS
👍️0
tknuncle tknuncle 3 years ago
Where is the bottom to XERS? I grabbed a a couple hundred a few days ago and it just keeps dropping more an more. Even after the good news today and yesterday. I was hoping maybe someone had an opinion they would like to share. Also does anyone know the real OS or Float? When I look at the OTC website I see it hasn't been updated since March 22nd.

https://www.otcmarkets.com/stock/SLS/security

Thanks for any feed back. Much appreciated
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Item 5.

Ownership of 5 Percent or Less of a Class. If this statement is being
filed to report the fact that as of the date hereof the reporting person
has ceased to be the beneficial owner of more than 5 percent of the
class of securities, check the following [ X ].
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Blackrock sold 2.1m shares into it since their last filing in May until today. If they are done suppressing it now, maybe it can finally head north to where it belongs.
👍️0
Modlich Modlich 3 years ago
Company on verge of bullish long run consolidated after bull flag bo last 2 days, imo anything over 5.2
and this could easily hit 7.8, breaks that or news stock can easily reach double digits.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Nom nom nom bring the gains.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
They are acquiring another company, which pushed the profitability timeline back and it reflected in that. That said, it'll cross the threshold a little harder. Some nice gains whether flipping or bottom feeding long.
👍️0
harr449 harr449 4 years ago
Recent announcement of deal caused PT to go from $14 to $9.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
You guys enjoying the start of this nice run?
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Delicious.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Once these conversions clear the landscape will probably change quick. I would think we are close too, but...
👍️0
I Dump I Dump 4 years ago
Falcon stocks has them as a buy this week. Holding off yet. Maybe bottom is near.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
So many conversions knocking the floor out of this thing. One day, pow, right in the kisser.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Conversions on this are still brutal. Float is low, one day she breaks the chains.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Good news out after hours. $$$
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Wonder if the convertible debt is done now. Looking like it may be. Gonna get interesting when it dries up.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Made some big buys over the last few days and all of them bared fruit today. Here's to the green mile.
👍️0
mte1955 mte1955 4 years ago
My thoughts exactly. Hopefully the dance continues for this and many other stocks.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Bought a bunch of 4.38's today. Flip forever and ever here. I still think it'll head north eventually.
👍️0
$Money Bags$ $Money Bags$ 4 years ago
Almost all of the convertible debt is extinguished. At current rate, probably in the next 10 days it will be gone at an average of $3ish a share, hence this hard drop. They have growing revenue, could be building the perfect storm. They have plenty of cash on hand. Started buying at $4.50 and have buys down to $3. Any takes on it?
👍️0
Termite7 Termite7 4 years ago
Good chart!!!
👍️0
trustbutverifyit trustbutverifyit 4 years ago
Amazed this board is so quiet on this ticker. It has been hopping on ST for a month now. $10 coming soon.
👍️0

Your Recent History

NASDAQ
XERS
Xeris Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads